Quick Dispatch:
Your foxo4-dri senolytic peptide human trial Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri senolytic peptide human trial Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ships.
Need Help?
Questions about foxo4-dri senolytic peptide human trial Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri senolytic peptide human trial Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells in your area.
Frontiers
25.71
FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation
27.45
TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS • The Journal of Prevention of Alzheimer's Disease
21.04
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
24.28
FOXO4-DRI (Proxofim)
20.69
Frontiers
24.59
FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway - Han - 2022 - Journal of Cellular and Molecular Medicine
24.99
